Lanreotide
Keywords
- Lanreotide Acetate
- maxime parabilis pretium
- CAS# 108736-35-2
Velox Details
- ProName:Lanreotide
- CasNo: 108736-35-2
- Formulae hypotheticae: C54H69N11O10S2
- Aspectus: cerussa
- Applicationem: Acromegaly Carcinoideum syndrome thyrot...
- DeliveryTime: promptum sit amet
- Sarcina: secundum elit scriptor requisitis
- Portus: Shenzhen
- ProductionCapacity: II Kilogram/mense
- Puritas: 98%
- Repono: 2~8℃. tuta lux
- Transportatio: per aerem
- LimitNum: 1 Gram
Superioritas
professional peptide fabrica in Sina.
princeps qualis est gmp gradus
magnis auctoribus pretium
nostra producta complectitur: mole generica apis peptidis, peptide medicatura, consuetudo peptides et peptides veterinarii.
Singula
Formulae hypotheticae
C54H69N11O10S2
Relativum Missae Molecularis
1096.34 g/mol
CAS-Number
108736-35-2 (retia), 127984-74-1 (acetate);
Long-term PRAECLUSIO
-20 ± 5°C
Synonyma
Angiopeptin; BIM-23014; DC-13-116;
(D-2-Nal5,Cys6,11,Tyr7,D-Trp8,Val10)-Somatostatin (5-12)
(D-2-Nal5,Cys6,11,Tyr7,D-Trp8,Val10)-Somatostatin (5-12)
Sequentia
HD-2-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide vinculum)
Agri Application
Acromegaly
Syndrome carcinoideum
Thyrotrophic adenomas
Syndrome carcinoideum
Thyrotrophic adenomas
Substantia activa
Lanreotide synthetica analogon somatostatin cum proprietatibus octreotide similis
Societas Profile:
societas nomen:Shenzhen JYMed Technologia Co.,Ltd.
Annus Constitutus: 2009
Capital: 89.5 Million RMB
Acetatum oxytocinum, acetatis vasopressinum, acetatis Desmopressin, acetatis terlipressin, acetatis Caspofungin, micafungin sodium, acetatis eptifibatidis, acetatis bivalirudin TFA, Deslorelini acetatis, acetatis glucagonis, acetatis histrelini, acetatis Caspofunginin, aceta- tis aeteris, acetatis elixatae, acetatis Bivalirudin TFA, deslorelin acetatis, glucagon. Acetate, Goserelin
Acetate, Argireline Acetate, Metrixyl Acetate, Snap VIII, ....
Studemus continuas innovationes in nova synthesi technologiae peptide et processu optimizationis, et nostra turma technica supra decennium experientiae in synthesi peptide.JYM feliciter multum submisit.
of ANDA peptide APIs et producta cum CFDA formata et plus quam quattuor patentes approbatae habent.
Nostra planta peptide in Nanjing sita, provincia Jiangsu et facilitatem 30,000 metrorum quadratorum posuit in obsequio cum indice cGMP. Facilitas artificiorum ab clientibus tam domesticis quam internationalibus est audita et inspecta.
Cum praestantissima qualitate, pretiosissima et validissima subsidia technica, JYM recognitiones non solum acquisivit pro suis Institutis Investigationis et industriarum pharmaceuticae, sed etiam unus factus est ex certissimis praebitoribus peptidum in Sinis. JYM dedicatum est unum esse provisor primarius peptidis mundi in proximo futuro.
Epistulam tuam hic scribe et mitte nobis
